Product Description: Elzovantinib (TPX-0022) is an oral-active inhibitor of SRC, MET and c-FMS, with IC50 values of 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively[1].
Applications: Cancer-Kinase/protease
Formula: C20H20FN7O2
References: [1]WO 2019023417 A1.
CAS Number: 2271119-26-5
Molecular Weight: 409.42
Compound Purity: 99.93
Research Area: Cancer
Solubility: DMSO : 25 mg/mL (ultrasonic)
Target: c-Fms;c-Met/HGFR;Src